Considerable share of patients admitted to the intensive care unit, during the current Covid-19 pandemic, are obese. Obesity is associated with chronic low-grade inflammation, higher endothelial injury, higher levels of angiotensinogen II and increased expression of angiotensin-converting enzyme 2 receptors in the adipose tissue. These alterations along with accompanying comorbidities make the obese patients susceptible for the development of severe respiratory complications, including acute respiratory distress syndrome (ARDS) during SARS-CoV-2 infection. The choice of optimal mode of oxygen delivery rests on both a prior patient's functional status and the progress and severity of Covid-19 in obese patients. Non-invasive ventilation and high-flow nasal cannula, prone position and hyperbaric oxygen therapy are effective in obese patients with mild or moderate ARDS. If mechanical ventilation is unavoidable, lung protective ventilation mode with lower tidal volume and optimal positive end-expiratory pressure is crucial for treatment of SARS-CoV-2-induced ARDS. Extracorporeal membrane oxygenation is reserved only for patients with inadequate response to previous oxygen therapy. Optimal knowledge of physiological changes in obesity and timely treatment with adequate oxygen therapy could improve clinical outcome of these sensitive patient subgroup.
References
1.
Zhang Y, Fang C, Dong BR, Wu T, Deng JL. Oxygen therapy for pneumonia in adults. Cochrane Database of Systematic Reviews. 2012(3).
2.
He G, Han Y, Fang Q. Clinical experience of high-flow nasal cannula oxygen therapy in severe COVID-19 patients. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020;49(2):232–9.
3.
Rocco M, Conti G, Alessandri E, Morelli A, Spadetta G, Laderchi A, et al. Rescue treatment for noninvasive ventilation failure due to interface intolerance with remifentanil analgosedation: a pilot study. Intensive Care Medicine. 2010;36(12):2060–5.
4.
Barrasa H, Rello J, Tejada S, Martín A, Balziskueta G, Vinuesa C, et al. SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria. Anaesthesia Critical Care & Pain Medicine. 2020;39(5):553–61.
5.
Nightingale R, Nwosu N, Kutubudin F, Fletcher T, Lewis J, Frost F, et al. Is continuous positive airway pressure (CPAP) a new standard of care for type 1 respiratory failure in COVID-19 patients? A retrospective observational study of a dedicated COVID-19 CPAP service. BMJ Open Respiratory Research. 2020;7(1):e000639.
6.
Gursel G, Aydogdu M, Gulbas G. The influence of severe obesity on non-invasive ventilation (NIV) strategies and responses in patients with acute hypercapnic respiratory failure attacks in the ICU. Minerva Anestesiol. 2011;77(17–25):21273965.
7.
Radovanovic D, Rizzi M, Pini S, Saad M, Chiumello DA, Santus P. Helmet CPAP to Treat Acute Hypoxemic Respiratory Failure in Patients with COVID-19: A Management Strategy Proposal. Journal of Clinical Medicine. 9(4):1191.
8.
Brewster DJ, Chrimes N, Do TB, Fraser K, Groombridge CJ, Higgs A, et al. Consensus statement: Safe Airway Society principles of airway management and tracheal intubation specific to the <scp>COVID</scp> ‐19 adult patient group. Medical Journal of Australia. 2020;212(10):472–81.
9.
Kang BJ, Koh Y, Lim CM, Huh JW, Baek S, Han M, et al. Failure of high-flow nasal cannula therapy may delay intubation and increase mortality. Intensive Care Medicine. 2015;41(4):623–32.
10.
Yao W, Wang T, Jiang B, Gao F, Wang L, Zheng H, et al. Emergency tracheal intubation in 202 patients with COVID-19 in Wuhan, China: lessons learnt and international expert recommendations. British Journal of Anaesthesia. 2020;125(1):e28–37.
11.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497–506.
12.
Raoof S, Nava S, Carpati C, Hill NS. High-Flow, Noninvasive Ventilation and Awake (Nonintubation) Proning in Patients With Coronavirus Disease 2019 With Respiratory Failure. Chest. 2020;158(5):1992–2002.
13.
Thibodeaux K, Speyrer M, Raza A, Yaakov R, Serena TE. Hyperbaric oxygen therapy in preventing mechanical ventilation in COVID-19 patients: a retrospective case series. Journal of Wound Care. 2020;29(Sup5a):S4–8.
14.
Despres C, Brunin Y, Berthier F, Pili-Floury S, Besch G. Prone positioning combined with high-flow nasal or conventional oxygen therapy in severe Covid-19 patients. Critical Care. 2020;24(1).
15.
Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine. 2020;8(5):475–81.
Nava S, Hill N. Non-invasive ventilation in acute respiratory failure. The Lancet. 2009;374(9685):250–9.
18.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061.
19.
Bonatti G, Robba C, Ball L, Silva PL, Rocco PRM, Pelosi P. Controversies when using mechanical ventilation in obese patients with and without acute distress respiratory syndrome. Expert Review of Respiratory Medicine. 2019;13(5):471–9.
20.
Ramanathan K, Antognini D, Combes A, Paden M, Zakhary B, Ogino M, et al. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases. The Lancet Respiratory Medicine. 2020;8(5):518–26.
21.
Alshahrani MS, Sindi A, Alshamsi F, Al-Omari A, El Tahan M, Alahmadi B, et al. Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus. Annals of Intensive Care. 2018;8(1).
22.
Aoyama H, Uchida K, Aoyama K, Pechlivanoglou P, Englesakis M, Yamada Y, et al. Assessment of Therapeutic Interventions and Lung Protective Ventilation in Patients With Moderate to Severe Acute Respiratory Distress Syndrome. JAMA Network Open. 2(7):e198116.
23.
De Jong A, Verzilli D, Jaber S. ARDS in Obese Patients: Specificities and Management. Critical Care. 23(1).
24.
Nestler C, Simon P, Petroff D, Hammermüller S, Kamrath D, Wolf S, et al. Individualized positive end-expiratory pressure in obese patients during general anaesthesia: a randomized controlled clinical trial using electrical impedance tomography. British Journal of Anaesthesia. 2017;119(6):1194–205.
25.
Kalra SS, Siuba M, Panitchote A, Mireles-Cabodevila E, Chatburn RL, Krishnan S, et al. Higher Class of Obesity Is Associated With Delivery of Higher Tidal Volumes in Subjects With ARDS. Respiratory Care. 2020;65(10):1519–26.
26.
Chen L, Brochard L. Lung volume assessment in acute respiratory distress syndrome. Current Opinion in Critical Care. 2015;21(3):259–64.
27.
Lewandowski K. Intensivtherapie bei Adipositas: Too Big to Fail? AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie. 2019;54(04):256–66.
28.
Mission WHOCJ. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19. Feb. 2020;
29.
Matthay MA, Aldrich JM, Gotts JE. Treatment for severe acute respiratory distress syndrome from COVID-19. The Lancet Respiratory Medicine. 2020;8(5):433–4.
30.
Wang J, Lu F, Zhou M. Tracheal intubation in patients with severe and critical COVID-19: analysis of 18 cases. Nan Fang Yi Ke Da Xue Xue Bao. 2020;40(3):337–41.
31.
DiSilvio B, Young M, Gordon A, Malik K, Singh A, Cheema T. Complications and Outcomes of Acute Respiratory Distress Syndrome. Critical Care Nursing Quarterly. 2019;42(4):349–61.
32.
Baker JG, Sovani M. Case for continuing community NIV and CPAP during the COVID-19 epidemic. Thorax. 2020;75(5):368–368.
33.
Simonds A, Hanak A, Chatwin M, Morrell M, Hall A, Parker K, et al. Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections. Health Technology Assessment. 14(46).
34.
Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol Generating Procedures and Risk of Transmission of Acute Respiratory Infections to Healthcare Workers: A Systematic Review. PLoS ONE. 7(4):e35797.
35.
Winck JC, Ambrosino N. COVID-19 pandemic and non invasive respiratory management: Every Goliath needs a David. An evidence based evaluation of problems. Pulmonology. 2020;26(4):213–20.
36.
Ramos EJB, Xu Y, Romanova I, Middleton F, Chen C, Quinn R, et al. Is obesity an inflammatory disease? Surgery. 2003;134(2):329–35.
37.
Kwaifa IK, Bahari H, Yong YK, Noor SM. Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications. Biomolecules. 10(2):291.
38.
Jain M, Budinger GRS, Lo A, Urich D, Rivera SE, Ghosh AK, et al. Leptin Promotes Fibroproliferative Acute Respiratory Distress Syndrome by Inhibiting Peroxisome Proliferator–activated Receptor-γ. American Journal of Respiratory and Critical Care Medicine. 2011;183(11):1490–8.
39.
Shah D, Romero F, Duong M, Wang N, Paudyal B, Suratt BT, et al. RETRACTED ARTICLE: Obesity-induced adipokine imbalance impairs mouse pulmonary vascular endothelial function and primes the lung for injury. Scientific Reports. 5(1).
40.
Pontiroli AE, Frigè F, Paganelli M, Folli F. In Morbid Obesity, Metabolic Abnormalities and Adhesion Molecules Correlate with Visceral Fat, Not with Subcutaneous Fat: Effect of Weight Loss Through Surgery. Obesity Surgery. 2009;19(6):745–50.
41.
Matarese G, Moschos S, Mantzoros CS. Leptin in Immunology. The Journal of Immunology. 2005;174(6):3137–42.
42.
Zhang X, Zheng J, Zhang L, Liu Y, Chen GP, Zhang HP, et al. Systemic inflammation mediates the detrimental effects of obesity on asthma control. Allergy and Asthma Proceedings. 2017;
43.
Huttunen R, Syrjänen J. Obesity and the risk and outcome of infection. International Journal of Obesity. 2013;37(3):333–40.
44.
Peters MC, McGrath KW, Hawkins GA, Hastie AT, Levy BD, Israel E, et al. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts. The Lancet Respiratory Medicine. 2016;4(7):574–84.
45.
Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury. Nature Medicine. 2005;11(8):875–9.
46.
Kim JA, Park HS. White blood cell count and abdominal fat distribution in female obese adolescents. Metabolism. 2008;57(10):1375–9.
47.
Gao F, Zheng KI, Wang XB, Sun QF, Pan KH, Wang TY, et al. Obesity Is a Risk Factor for Greater COVID-19 Severity. Diabetes Care. 2020;43(7):e72–4.
48.
Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The Lancet Respiratory Medicine. 2020;8(4):e21.
49.
Elagizi A, Kachur S, Lavie CJ, Carbone S, Pandey A, Ortega FB, et al. An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases. Progress in Cardiovascular Diseases. 2018;61(2):142–50.
50.
Lavie CJ, Laddu D, Arena R, Ortega FB, Alpert MA, Kushner RF. Healthy Weight and Obesity Prevention. Journal of the American College of Cardiology. 2018;72(13):1506–31.
51.
Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in Critically Ill Patients in the Seattle Region — Case Series. New England Journal of Medicine. 2020;382(21):2012–22.
52.
High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) Requiring Invasive Mechanical Ventilation. Obesity. 2020;28(10):1994–1994.
53.
Dixon AE, Peters U. The effect of obesity on lung function. Expert Rev Respir Med. 2018;12(9):755–67.
54.
Ball L, Pelosi P. How I ventilate an obese patient. Critical Care. 2019;23(1).
55.
Moriconi D, Masi S, Rebelos E, Virdis A, Manca ML, De Marco S, et al. Obesity prolongs the hospital stay in patients affected by COVID-19, and may impact on SARS-COV-2 shedding. Obesity Research & Clinical Practice. 2020;14(3):205–9.
56.
Caputo ND, Strayer RJ, Levitan R. Early Self‐Proning in Awake, Non‐intubated Patients in the Emergency Department: A Single ED’s Experience During the COVID‐19 Pandemic. Academic Emergency Medicine. 2020;27(5):375–8.
57.
Samad F, Ruf W. Inflammation, obesity, and thrombosis. Blood. 2013;122(20):3415–22.
58.
Radu CM, Spiezia L, Gavasso S, Fadin M, Woodhams B, Vettor R, et al. Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events. Thrombosis and Haemostasis. 2015;113(01):85–96.
59.
Darvall KAL, Sam RC, Silverman SH, Bradbury AW, Adam DJ. Obesity and Thrombosis. European Journal of Vascular and Endovascular Surgery. 2007;33(2):223–33.
60.
Jin J. Obesity and the Heart. JAMA. 2013;310(19):2113.
61.
Busetto L, Bettini S, Fabris R, Serra R, Dal Pra C, Maffei P, et al. Obesity and COVID‐19: An Italian Snapshot. Obesity. 2020;28(9):1600–5.
62.
Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323(20):2052.
63.
Murugan A, Sharma G. Obesity and respiratory diseases. Chronic Respiratory Disease. 2008;5(4):233–42.
64.
Saiki A, Ohira M, Endo K, Koide N, Oyama T, Murano T, et al. Circulating angiotensin II is associated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitus. Metabolism. 2009;58(5):708–13.
65.
Clinical Characteristics of Covid-19 in China. New England Journal of Medicine. 2020;382(19):1859–62.
66.
Cabandugama PK, Gardner MJ, Sowers JR. The Renin Angiotensin Aldosterone System in Obesity and Hypertension. Medical Clinics of North America. 2017;101(1):129–37.
67.
Bornstein SR, Dalan R, Hopkins D, Mingrone G, Boehm BO. Endocrine and metabolic link to coronavirus infection. Nature Reviews Endocrinology. 2020;16(6):297–8.
68.
Lakkis JI, Weir MR. Obesity and Kidney Disease. Progress in Cardiovascular Diseases. 2018;61(2):157–67.
69.
Jia X, Yin C, Lu S, Chen Y, Liu Q, Bai J, et al. Two Things about COVID-19 Might Need Attention.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
